The vaccine, which was developed in partnership with Oxford University, is awaiting approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for use among children. It was greenlit by British regulators for use in adults at the end of 2020. “Whilst there are no safety concerns in the paediatric …
Read More »
Canberra is still waiting for more than 3 million doses of AstraZeneca’s jab that were supposed to be delivered from abroad. Speaking with Sky News on Tuesday, Acting Chief Medical Officer Michael Kidd said that the shortage was the result of “problems with shipments that we’ve seen happening here and …
Read More »
The US Department of Health & Human Services has given Johnson & Johnson full responsibility of the Emergent BioSolutions facility following the error to avoid such an accident again, and AstraZeneca is now looking for a new production place, according to an unnamed health official who spoke to the New …
Read More »
The British-Swedish pharmaceutical has rebranded its jab, which previously went by the simple ‘AstraZeneca Covid-19 Vaccine’, to ‘Vaxzevria’. In a press release, the company said that the name change does not involve any alterations to the actual drug. Medical workers should be made aware of the rebrand though, the firm …
Read More »
The move comes after a recommendation from Canada’s National Advisory Committee on Immunization on Monday, which called for a pause to buy time to evaluate the safety concerns, namely over a rare blood clotting condition known as vaccine-induced prothrombotic immune thrombocytopenia, or VIPIT. “There is substantial uncertainty about the benefit …
Read More »
The pharma firm publicized the results of its 32,000-person US trial in the early hours of Thursday morning, reporting that the immunization is 76% effective overall and 100% effective in staving off “critical disease and hospitalization” from Covid-19. For adults over the age of 65, the company put the figure …
Read More »
On Monday, the pharmaceutical giant released promising interim results from its US study, which showed its drug to have 79% efficacy in stopping symptomatic Covid-19 and to be 100% effective at preventing severe cases and hospitalization. The firm also said that the results showed that the drug does not cause …
Read More »
On Monday, the embattled pharmaceutical giant AstraZeneca published positive results from its US trial, which showed the jab to have 79% efficacy in preventing symptomatic Covid-19 and to be 100% effective at preventing severe disease and hospitalization. The study, which involved over 32,000 participants, found no increased risk of thrombotic …
Read More »
“We have the option of prohibiting a planned export. That is the message to AstraZeneca,” the EU Commission president told German media on Saturday. “You first fulfil your contract with Europe before you start delivering to other countries.” Von der Leyen blamed the Anglo-Swedish company for having delivered only 30% …
Read More »
A research team from Germany’s Greifswald University Hospital have discovered a mechanism that could lead to the development of sinus or cerebral vein thrombosis in patients who received the AstraZeneca jab. The team received six blood samples of people who suffered from thrombosis after taking the jab. The samples were …
Read More »